期刊文献+

不同程度宫颈病变感染人乳头瘤病毒的优势亚型 被引量:9

Optimal HPV Genotype of Women with Different Stages of Cervica Lesions
下载PDF
导出
摘要 目的研究不同程度子宫颈病变感染人乳头瘤病毒(humam papillomavirus,HPV)的优势亚型。方法选取子宫颈病变患者270例,其中组织学检查示典型HPV感染改变者54例、CIN1 85例、CIN2 63例、CIN3 48例、子宫颈癌20例。低度鳞状上皮内病变(low-grade squamous intraepithelial lesion,LSIL)包括HPV感染改变者和CIN1,高度鳞状上皮内病变(high-grade squamous intraepithelial lesion,HSIL)包括CIN2和CIN3。采用HPV基因芯片检测及分型方法检测所有患者子宫颈分泌物中的HPV亚型。结果270例子宫颈分泌物中HPV亚型感染频度由高到低的前5位依次为HPV-16(49.7%)、HPV-58(16.8%)、HPV-18(12.6%)、HPV-33(9.0%)、HPV-31(6.0%),而其余亚型所占比例均小于4.0%。子宫颈病变分级不同,感染的HPV亚型亦有区别。HSIL组HPV感染型别前5位由高至低依次为:HPV-16、58、18、33和31,感染率分别为62.6%、14.1%、11.1%、8.1%和6.1%,在HSIL中此5种亚型感染覆盖率为90.8%;而LSIL组HPV感染型别由高至低依次为:HPV-16、18、58、33和31,感染率分别为21.7%、19.6%、17.4%、8.7%和6.5%,其余亚型所占比例均小于5%,LSIL中此5种亚型感染覆盖率为69.6%。采用χ2检验发现,HSIL组HPV-16型感染率明显高于LSIL组,差异具有显著性意义(P<0.05),而LSIL组HPV-18型感染率明显高于HSIL组,差异具有显著性意义(P<0.05)。结论不同程度子宫颈病变感染HPV的优势亚型不同。HPV-16、58、18、33和31型的致癌性较强,其中HPV-16型最强。 Objective To investigate the optimal HPV genotype of women with different stages of cervical lesions.Methods 270 women with different stages of cervical intraepithelial neoplasia(CIN),including 54 cases of human papillomavirus(HPV) infection,85 cases of CIN1,63 cases of CIN2,48 cases of CIN3 and 20 cases of cervical cancer,were studied.High-grade squamous intraepithelial lesions(HSIL): CIN2 and CIN3,and low-grade squamous intraepithelial lesions(LSIL): CIN1 and HPV infection.The HPV genotype in the cervical swabs of these patients was detected by HPV gene chip.Results In the cervical swabs of 270 patients,the prevalence of the first 5 HPV types from highest to lowest order was as follows: HPV-16(49.7%),HPV-58(16.8%),HPV-18(12.6%),HPV-33(9.0%) and HPV-31(6.0%).The prevalence of the other HPV types was less than 4%.The infected HPV genotypes were different in different stages of cervical lesion.The prevalence of the first 5 HPV types in HSIL cases from highest to lowest order was as follows: HPV-16(62.6%), HPV-58(14.1%),HPV-18(11.1%),HPV-33(8.1%) and HPV-31(6.1%) with the coverage being 90.8%.The prevalence of the first 5 HPV types in LSIL cases from highest to lowest order was as follows: HPV-16(21.7%),HPV-18(19.6%),HPV-58(17.4%),HPV-33(8.7%) and HPV-31(6.5%) with the coverage being 69.6%.χ~2 analysis revealed that the HPV-16 infection rate of HSIL was significantly higher than that of LSIL(P<0.05),while the HPV-18 infection rate of LSIL was significantly higher than that of HSIL(P<0.05).Conclusion The optimal HPV genotype of women with different stages of cervical lesions is different.HPV-16,HPV-58,HPV-18,HPV-33 and HPV-31 are more oncogenic,and HPV-16 is the most oncogenic type.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2006年第6期771-773,共3页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
关键词 子宫颈病变 人乳头瘤病毒亚型 基因芯片 子宫颈癌 cervical lesions humam papillomavirus genotype gene chip cervical cancer
  • 相关文献

参考文献10

  • 1[1]AN H J,CHON H,LEE S Y,et al.Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method[J].Cancer,2003,97(7):1672-1680.
  • 2[2]KIM C J,JEONG J K,PARK M,et al.HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions[J].Gvnecol Oncol,2003,89(2):210-217.
  • 3李瑞珍,石菊芳,周庆芝,吴瑞芳,李霓,乌兰娜,周艳秋,王倩,刘志红,刘彬,乔友林.应用基因芯片技术检测高危型人乳头瘤病毒在宫颈癌筛查中的评价[J].中华医学杂志,2006,86(5):307-311. 被引量:52
  • 4[4]SCHIFFMAN M,KHAN M J,SOLOMAN D,et al.A study of the impact of adding HPV types to cervical cancer screening and triage tests[J].J Natl Cancer Inst,2005,97(2):147-150.
  • 5[5]MARGARET E C.The role of human papillomavirus in risk management[J].Gynecol Prac,2003,3 (3):229-233.
  • 6[6]ARC working group on the evaluation of carcinogenic risks to humans.IARC monographs on the evaluation of carcinogenic risks to humans.Human papillomavirus[M].Lyon,France:WHO,1995,64.
  • 7[7]WU Y,CHEN Y,LI L,et al.Associations of high-risk HPV types and viral load with cervical cancer in China[J].J Clin Virol,2006,35(3):264-269.
  • 8[8]TRIMBLE C L,PIANTADOSI S,GRAVITT P,et al.Spontaneous regression of high-grade cervical dysplasia:effects of human papillomavirus type and HLA phenotype[J].Clin Cancer Res,2005,11 (3):4717-4723.
  • 9[9]ANDERSSON S,SAFARI H,MINTS M,et al.Type distribution,viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN)[J].Br J Cancer,2005,92(12):2195-200.
  • 10丰有吉.子宫颈上皮内瘤变[J].实用肿瘤杂志,2003,18(3):169-171. 被引量:16

二级参考文献9

  • 1李从铸,翟玉霞.宫颈癌年轻化及其治疗模式的临床研究[J].癌变.畸变.突变,2005,17(1):36-38. 被引量:21
  • 2刘彬,陈汶,任生达,刘新伏,马俊飞,崔剑峰,王秀荣,陈凤,乔友林.液基细胞学剩余标本筛查子宫颈病变中人乳头状瘤病毒DNA的应用[J].中华检验医学杂志,2005,28(5):495-497. 被引量:18
  • 3Mtmoz N, Bosch FX, Sanjose S, et al. Epidermiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med,2003,348:518-527.
  • 4Richart RM. A modified terminology for cervical intraepithelial neoplasia. Obstet Gynecol, 1990,75 : 131-133.
  • 5WHO IARC. Carcinogenicity of human papillomaviruses. Lancet Oncology, 2005,6 : 204 -204.
  • 6Komegay JR, Roger M, Davies PO, et al. International proficiency study of a consensus L1 PCR assay for the detection and typing of human papillomavirus DNA : evaluation of accuracy and intralaboratory and interlaboratory agreement. J Clin Microbial,2003,41 : 1080-1086.
  • 7Striekler H, Shah K. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance :baseline results from a randomized trial. J Natl Cancer Inst, 2001,93:951-952.
  • 8Nicolas FS, Audrea T, Eliane, et al. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer, 2003,103 :519-524.
  • 9乔友林,章文华,李凌,潘秦镜,杨玲,吴令英,戍寿德,李爱玲,张询,任生达,Belinson J.子宫颈癌筛查方法的横断面比较研究[J].中国医学科学院学报,2002,24(1):50-53. 被引量:351

共引文献66

同被引文献98

引证文献9

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部